nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—CES2—Mycophenolate mofetil—psoriasis	0.31	0.371	CbGbCtD
Dabigatran etexilate—UGT1A9—Mycophenolic acid—psoriasis	0.117	0.14	CbGbCtD
Dabigatran etexilate—UGT2B7—Mycophenolic acid—psoriasis	0.111	0.132	CbGbCtD
Dabigatran etexilate—CES1—Mycophenolate mofetil—psoriasis	0.108	0.129	CbGbCtD
Dabigatran etexilate—UGT1A9—Mycophenolate mofetil—psoriasis	0.0653	0.0782	CbGbCtD
Dabigatran etexilate—UGT2B7—Mycophenolate mofetil—psoriasis	0.0618	0.074	CbGbCtD
Dabigatran etexilate—ABCB1—Mycophenolate mofetil—psoriasis	0.0106	0.0127	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—psoriasis	0.00908	0.0109	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—psoriasis	0.00896	0.0107	CbGbCtD
Dabigatran etexilate—ABCB1—Hydrocortisone—psoriasis	0.0085	0.0102	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—psoriasis	0.00846	0.0101	CbGbCtD
Dabigatran etexilate—ABCB1—Cyclosporine—psoriasis	0.00802	0.00961	CbGbCtD
Dabigatran etexilate—ABCB1—Dexamethasone—psoriasis	0.00528	0.00633	CbGbCtD
Dabigatran etexilate—ABCB1—Methotrexate—psoriasis	0.00425	0.00509	CbGbCtD
Dabigatran etexilate—F2—vertebral column—psoriasis	0.000137	0.51	CbGeAlD
Dabigatran etexilate—Angiopathy—Betamethasone—psoriasis	0.000136	0.000821	CcSEcCtD
Dabigatran etexilate—Infection—Mycophenolate mofetil—psoriasis	0.000135	0.00082	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—psoriasis	0.000135	0.000815	CcSEcCtD
Dabigatran etexilate—Shock—Mycophenolate mofetil—psoriasis	0.000134	0.000813	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Hydrocortisone—psoriasis	0.000134	0.00081	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000134	0.00081	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000134	0.000809	CcSEcCtD
Dabigatran etexilate—Skin disorder—Mycophenolate mofetil—psoriasis	0.000132	0.000802	CcSEcCtD
Dabigatran etexilate—Hypertension—Hydrocortisone—psoriasis	0.000131	0.000796	CcSEcCtD
Dabigatran etexilate—Vomiting—Hydroxyurea—psoriasis	0.000131	0.000794	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—psoriasis	0.000131	0.000793	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—psoriasis	0.000131	0.000792	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Methotrexate—psoriasis	0.00013	0.000789	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—psoriasis	0.00013	0.000788	CcSEcCtD
Dabigatran etexilate—Rash—Hydroxyurea—psoriasis	0.00013	0.000788	CcSEcCtD
Dabigatran etexilate—Dermatitis—Hydroxyurea—psoriasis	0.00013	0.000787	CcSEcCtD
Dabigatran etexilate—Headache—Hydroxyurea—psoriasis	0.000129	0.000783	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000129	0.000779	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—psoriasis	0.000129	0.000778	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—psoriasis	0.000128	0.000774	CcSEcCtD
Dabigatran etexilate—Hypotension—Mycophenolate mofetil—psoriasis	0.000127	0.000772	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000127	0.000771	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—psoriasis	0.000127	0.00077	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Methotrexate—psoriasis	0.000126	0.000765	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—psoriasis	0.000126	0.000763	CcSEcCtD
Dabigatran etexilate—Shock—Prednisolone—psoriasis	0.000125	0.000758	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—psoriasis	0.000125	0.000758	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Cyclosporine—psoriasis	0.000125	0.000755	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000124	0.000752	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Hydrocortisone—psoriasis	0.000124	0.000752	CcSEcCtD
Dabigatran etexilate—Asthenia—Mycophenolic acid—psoriasis	0.000124	0.000751	CcSEcCtD
Dabigatran etexilate—Hypertension—Triamcinolone—psoriasis	0.000124	0.000749	CcSEcCtD
Dabigatran etexilate—Infection—Hydrocortisone—psoriasis	0.000123	0.000747	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Cyclosporine—psoriasis	0.000123	0.000745	CcSEcCtD
Dabigatran etexilate—Nausea—Hydroxyurea—psoriasis	0.000123	0.000742	CcSEcCtD
Dabigatran etexilate—Pruritus—Mycophenolic acid—psoriasis	0.000122	0.00074	CcSEcCtD
Dabigatran etexilate—Shock—Hydrocortisone—psoriasis	0.000122	0.00074	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Hydrocortisone—psoriasis	0.000122	0.000738	CcSEcCtD
Dabigatran etexilate—Pneumonia—Methotrexate—psoriasis	0.000122	0.000738	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000122	0.000736	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methotrexate—psoriasis	0.000121	0.000734	CcSEcCtD
Dabigatran etexilate—Infestation—Methotrexate—psoriasis	0.000121	0.000734	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000121	0.000731	CcSEcCtD
Dabigatran etexilate—Skin disorder—Hydrocortisone—psoriasis	0.000121	0.000731	CcSEcCtD
Dabigatran etexilate—Fatigue—Cyclosporine—psoriasis	0.000121	0.00073	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00012	0.000727	CcSEcCtD
Dabigatran etexilate—Constipation—Cyclosporine—psoriasis	0.00012	0.000724	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—psoriasis	0.000119	0.00072	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—psoriasis	0.000119	0.00072	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Mycophenolic acid—psoriasis	0.000118	0.000716	CcSEcCtD
Dabigatran etexilate—Angiopathy—Prednisone—psoriasis	0.000118	0.000715	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000118	0.000713	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—psoriasis	0.000118	0.000712	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—psoriasis	0.000117	0.000708	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—psoriasis	0.000117	0.000706	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—psoriasis	0.000117	0.000706	CcSEcCtD
Dabigatran etexilate—Constipation—Mycophenolate mofetil—psoriasis	0.000117	0.000706	CcSEcCtD
Dabigatran etexilate—Infection—Triamcinolone—psoriasis	0.000116	0.000704	CcSEcCtD
Dabigatran etexilate—Hypotension—Hydrocortisone—psoriasis	0.000116	0.000703	CcSEcCtD
Dabigatran etexilate—Haematuria—Methotrexate—psoriasis	0.000115	0.000699	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—psoriasis	0.000115	0.000697	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Methotrexate—psoriasis	0.000115	0.000694	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Cyclosporine—psoriasis	0.000114	0.000692	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—psoriasis	0.000114	0.000692	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—psoriasis	0.000114	0.000692	CcSEcCtD
Dabigatran etexilate—Dizziness—Mycophenolic acid—psoriasis	0.000114	0.000692	CcSEcCtD
Dabigatran etexilate—Epistaxis—Methotrexate—psoriasis	0.000114	0.000692	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—psoriasis	0.000113	0.000686	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000113	0.000686	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—psoriasis	0.000112	0.00068	CcSEcCtD
Dabigatran etexilate—Hypertension—Dexamethasone—psoriasis	0.000112	0.00068	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000112	0.000675	CcSEcCtD
Dabigatran etexilate—Urticaria—Cyclosporine—psoriasis	0.000111	0.000673	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Cyclosporine—psoriasis	0.000111	0.000669	CcSEcCtD
Dabigatran etexilate—Vomiting—Mycophenolic acid—psoriasis	0.00011	0.000665	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Hydrocortisone—psoriasis	0.000109	0.000662	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methotrexate—psoriasis	0.000109	0.000662	CcSEcCtD
Dabigatran etexilate—Rash—Mycophenolic acid—psoriasis	0.000109	0.00066	CcSEcCtD
Dabigatran etexilate—Dermatitis—Mycophenolic acid—psoriasis	0.000109	0.000659	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methotrexate—psoriasis	0.000109	0.000659	CcSEcCtD
Dabigatran etexilate—Urticaria—Mycophenolate mofetil—psoriasis	0.000108	0.000656	CcSEcCtD
Dabigatran etexilate—Headache—Mycophenolic acid—psoriasis	0.000108	0.000656	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000108	0.000653	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Methotrexate—psoriasis	0.000107	0.00065	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000107	0.00065	CcSEcCtD
Dabigatran etexilate—Fatigue—Hydrocortisone—psoriasis	0.000107	0.000649	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Methotrexate—psoriasis	0.000107	0.000646	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000107	0.000645	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—psoriasis	0.000106	0.000643	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—psoriasis	0.000106	0.000643	CcSEcCtD
Dabigatran etexilate—Infection—Betamethasone—psoriasis	0.000105	0.000639	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—psoriasis	0.000105	0.000639	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—psoriasis	0.000105	0.000634	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—psoriasis	0.000104	0.000632	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—psoriasis	0.000104	0.000632	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—psoriasis	0.000104	0.000632	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—psoriasis	0.000104	0.00063	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—psoriasis	0.000104	0.00063	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—psoriasis	0.000104	0.000629	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—psoriasis	0.000104	0.000629	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—psoriasis	0.000103	0.000627	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Cyclosporine—psoriasis	0.000103	0.000624	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—psoriasis	0.000103	0.000624	CcSEcCtD
Dabigatran etexilate—Nausea—Mycophenolic acid—psoriasis	0.000103	0.000622	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000102	0.000615	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—psoriasis	0.000102	0.000615	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisolone—psoriasis	0.000101	0.000612	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methotrexate—psoriasis	0.000101	0.000611	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—psoriasis	0.000101	0.000611	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.0001	0.000608	CcSEcCtD
Dabigatran etexilate—Asthenia—Cyclosporine—psoriasis	0.0001	0.000607	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisone—psoriasis	9.96e-05	0.000603	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—psoriasis	9.92e-05	0.000601	CcSEcCtD
Dabigatran etexilate—Hypotension—Dexamethasone—psoriasis	9.92e-05	0.000601	CcSEcCtD
Dabigatran etexilate—Pruritus—Cyclosporine—psoriasis	9.89e-05	0.000599	CcSEcCtD
Dabigatran etexilate—Urticaria—Hydrocortisone—psoriasis	9.87e-05	0.000598	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methotrexate—psoriasis	9.87e-05	0.000597	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methotrexate—psoriasis	9.82e-05	0.000595	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Hydrocortisone—psoriasis	9.82e-05	0.000595	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methotrexate—psoriasis	9.8e-05	0.000593	CcSEcCtD
Dabigatran etexilate—Asthenia—Mycophenolate mofetil—psoriasis	9.78e-05	0.000593	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisone—psoriasis	9.78e-05	0.000592	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—psoriasis	9.67e-05	0.000586	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—psoriasis	9.67e-05	0.000586	CcSEcCtD
Dabigatran etexilate—Pruritus—Mycophenolate mofetil—psoriasis	9.65e-05	0.000584	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—psoriasis	9.64e-05	0.000584	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	9.58e-05	0.00058	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Cyclosporine—psoriasis	9.57e-05	0.000579	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methotrexate—psoriasis	9.47e-05	0.000573	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisolone—psoriasis	9.37e-05	0.000568	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—psoriasis	9.34e-05	0.000566	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—psoriasis	9.34e-05	0.000566	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Mycophenolate mofetil—psoriasis	9.33e-05	0.000565	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—psoriasis	9.29e-05	0.000563	CcSEcCtD
Dabigatran etexilate—Dizziness—Cyclosporine—psoriasis	9.24e-05	0.00056	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—psoriasis	9.24e-05	0.00056	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—psoriasis	9.18e-05	0.000556	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—psoriasis	9.16e-05	0.000555	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—psoriasis	9.16e-05	0.000555	CcSEcCtD
Dabigatran etexilate—Back pain—Methotrexate—psoriasis	9.16e-05	0.000555	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Hydrocortisone—psoriasis	9.15e-05	0.000554	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—psoriasis	9.15e-05	0.000554	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—psoriasis	9.15e-05	0.000554	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—psoriasis	9.09e-05	0.000551	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—psoriasis	9.07e-05	0.000549	CcSEcCtD
Dabigatran etexilate—Dizziness—Mycophenolate mofetil—psoriasis	9.02e-05	0.000546	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—psoriasis	8.98e-05	0.000544	CcSEcCtD
Dabigatran etexilate—Asthenia—Hydrocortisone—psoriasis	8.91e-05	0.00054	CcSEcCtD
Dabigatran etexilate—Vomiting—Cyclosporine—psoriasis	8.89e-05	0.000538	CcSEcCtD
Dabigatran etexilate—Rash—Cyclosporine—psoriasis	8.81e-05	0.000534	CcSEcCtD
Dabigatran etexilate—Dermatitis—Cyclosporine—psoriasis	8.81e-05	0.000533	CcSEcCtD
Dabigatran etexilate—Pruritus—Hydrocortisone—psoriasis	8.79e-05	0.000532	CcSEcCtD
Dabigatran etexilate—Headache—Cyclosporine—psoriasis	8.76e-05	0.00053	CcSEcCtD
Dabigatran etexilate—Anaemia—Methotrexate—psoriasis	8.75e-05	0.00053	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—psoriasis	8.68e-05	0.000526	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—psoriasis	8.68e-05	0.000526	CcSEcCtD
Dabigatran etexilate—Vomiting—Mycophenolate mofetil—psoriasis	8.67e-05	0.000525	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—psoriasis	8.62e-05	0.000522	CcSEcCtD
Dabigatran etexilate—Rash—Mycophenolate mofetil—psoriasis	8.6e-05	0.000521	CcSEcCtD
Dabigatran etexilate—Dermatitis—Mycophenolate mofetil—psoriasis	8.59e-05	0.00052	CcSEcCtD
Dabigatran etexilate—Headache—Mycophenolate mofetil—psoriasis	8.54e-05	0.000517	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Hydrocortisone—psoriasis	8.5e-05	0.000515	CcSEcCtD
Dabigatran etexilate—Urticaria—Dexamethasone—psoriasis	8.43e-05	0.000511	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—psoriasis	8.43e-05	0.000511	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—psoriasis	8.42e-05	0.00051	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—psoriasis	8.41e-05	0.000509	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—psoriasis	8.39e-05	0.000508	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—psoriasis	8.39e-05	0.000508	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—psoriasis	8.39e-05	0.000508	CcSEcCtD
Dabigatran etexilate—Nausea—Cyclosporine—psoriasis	8.3e-05	0.000503	CcSEcCtD
Dabigatran etexilate—Pruritus—Triamcinolone—psoriasis	8.28e-05	0.000501	CcSEcCtD
Dabigatran etexilate—Cough—Methotrexate—psoriasis	8.26e-05	0.0005	CcSEcCtD
Dabigatran etexilate—Dizziness—Hydrocortisone—psoriasis	8.22e-05	0.000498	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Prednisone—psoriasis	8.14e-05	0.000493	CcSEcCtD
Dabigatran etexilate—Nausea—Mycophenolate mofetil—psoriasis	8.1e-05	0.000491	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methotrexate—psoriasis	8.06e-05	0.000488	CcSEcCtD
Dabigatran etexilate—Chest pain—Methotrexate—psoriasis	8.06e-05	0.000488	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—psoriasis	8.02e-05	0.000486	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—psoriasis	8.01e-05	0.000485	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8e-05	0.000485	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—psoriasis	7.97e-05	0.000483	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—psoriasis	7.97e-05	0.000483	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—psoriasis	7.91e-05	0.000479	CcSEcCtD
Dabigatran etexilate—Vomiting—Hydrocortisone—psoriasis	7.9e-05	0.000478	CcSEcCtD
Dabigatran etexilate—Rash—Hydrocortisone—psoriasis	7.83e-05	0.000474	CcSEcCtD
Dabigatran etexilate—Dermatitis—Hydrocortisone—psoriasis	7.83e-05	0.000474	CcSEcCtD
Dabigatran etexilate—Headache—Hydrocortisone—psoriasis	7.78e-05	0.000471	CcSEcCtD
Dabigatran etexilate—Dizziness—Triamcinolone—psoriasis	7.74e-05	0.000468	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methotrexate—psoriasis	7.73e-05	0.000468	CcSEcCtD
Dabigatran etexilate—Infection—Methotrexate—psoriasis	7.68e-05	0.000465	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—psoriasis	7.62e-05	0.000461	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—psoriasis	7.62e-05	0.000461	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methotrexate—psoriasis	7.58e-05	0.000459	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Methotrexate—psoriasis	7.56e-05	0.000458	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—psoriasis	7.56e-05	0.000458	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—psoriasis	7.56e-05	0.000458	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—psoriasis	7.51e-05	0.000455	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—psoriasis	7.51e-05	0.000455	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methotrexate—psoriasis	7.5e-05	0.000454	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—psoriasis	7.44e-05	0.00045	CcSEcCtD
Dabigatran etexilate—Nausea—Hydrocortisone—psoriasis	7.38e-05	0.000447	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—psoriasis	7.38e-05	0.000447	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—psoriasis	7.37e-05	0.000446	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—psoriasis	7.34e-05	0.000445	CcSEcCtD
Dabigatran etexilate—Headache—Triamcinolone—psoriasis	7.33e-05	0.000444	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—psoriasis	7.31e-05	0.000443	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—psoriasis	7.26e-05	0.00044	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dexamethasone—psoriasis	7.26e-05	0.00044	CcSEcCtD
Dabigatran etexilate—Hypotension—Methotrexate—psoriasis	7.22e-05	0.000437	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methotrexate—psoriasis	7.04e-05	0.000426	CcSEcCtD
Dabigatran etexilate—Dizziness—Dexamethasone—psoriasis	7.02e-05	0.000425	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—psoriasis	7.02e-05	0.000425	CcSEcCtD
Dabigatran etexilate—Nausea—Triamcinolone—psoriasis	6.95e-05	0.000421	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Methotrexate—psoriasis	6.89e-05	0.000417	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisone—psoriasis	6.81e-05	0.000412	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methotrexate—psoriasis	6.8e-05	0.000412	CcSEcCtD
Dabigatran etexilate—Vomiting—Dexamethasone—psoriasis	6.75e-05	0.000409	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—psoriasis	6.75e-05	0.000409	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—psoriasis	6.69e-05	0.000405	CcSEcCtD
Dabigatran etexilate—Rash—Dexamethasone—psoriasis	6.69e-05	0.000405	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—psoriasis	6.69e-05	0.000405	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—psoriasis	6.69e-05	0.000405	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Methotrexate—psoriasis	6.67e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Fatigue—Methotrexate—psoriasis	6.66e-05	0.000403	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—psoriasis	6.65e-05	0.000403	CcSEcCtD
Dabigatran etexilate—Headache—Betamethasone—psoriasis	6.65e-05	0.000403	CcSEcCtD
Dabigatran etexilate—Asthenia—Prednisone—psoriasis	6.63e-05	0.000402	CcSEcCtD
Dabigatran etexilate—Pruritus—Prednisone—psoriasis	6.54e-05	0.000396	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Prednisone—psoriasis	6.33e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methotrexate—psoriasis	6.32e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—psoriasis	6.31e-05	0.000382	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—psoriasis	6.31e-05	0.000382	CcSEcCtD
Dabigatran etexilate—Urticaria—Methotrexate—psoriasis	6.14e-05	0.000372	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisone—psoriasis	6.11e-05	0.00037	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methotrexate—psoriasis	6.11e-05	0.00037	CcSEcCtD
Dabigatran etexilate—F2—endothelium—psoriasis	6.08e-05	0.227	CbGeAlD
Dabigatran etexilate—Vomiting—Prednisone—psoriasis	5.88e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Rash—Prednisone—psoriasis	5.83e-05	0.000353	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—psoriasis	5.82e-05	0.000353	CcSEcCtD
Dabigatran etexilate—Headache—Prednisone—psoriasis	5.79e-05	0.000351	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methotrexate—psoriasis	5.69e-05	0.000345	CcSEcCtD
Dabigatran etexilate—Asthenia—Methotrexate—psoriasis	5.54e-05	0.000336	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisone—psoriasis	5.49e-05	0.000333	CcSEcCtD
Dabigatran etexilate—Pruritus—Methotrexate—psoriasis	5.47e-05	0.000331	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methotrexate—psoriasis	5.29e-05	0.00032	CcSEcCtD
Dabigatran etexilate—Dizziness—Methotrexate—psoriasis	5.11e-05	0.000309	CcSEcCtD
Dabigatran etexilate—Vomiting—Methotrexate—psoriasis	4.91e-05	0.000297	CcSEcCtD
Dabigatran etexilate—Rash—Methotrexate—psoriasis	4.87e-05	0.000295	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methotrexate—psoriasis	4.87e-05	0.000295	CcSEcCtD
Dabigatran etexilate—Headache—Methotrexate—psoriasis	4.84e-05	0.000293	CcSEcCtD
Dabigatran etexilate—Nausea—Methotrexate—psoriasis	4.59e-05	0.000278	CcSEcCtD
Dabigatran etexilate—CES2—skin of body—psoriasis	2.9e-05	0.108	CbGeAlD
Dabigatran etexilate—CES2—tendon—psoriasis	2.2e-05	0.0822	CbGeAlD
Dabigatran etexilate—NQO2—tendon—psoriasis	1.97e-05	0.0734	CbGeAlD
